Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.860
+0.160 (9.41%)
At close: Mar 31, 2026, 4:00 PM EDT
1.710
-0.150 (-8.06%)
After-hours: Mar 31, 2026, 7:56 PM EDT

Co-Diagnostics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.623.926.8134.2297.89
Revenue Growth (YoY)
-84.10%-42.53%-80.09%-65.04%31.30%
Cost of Revenue
0.2214.185.4811.57
Gross Profit
0.42.922.6328.7486.31
Selling, General & Admin
11.4420.6421.1421.6124.95
Depreciation & Amortization Expenses
1.111.381.231.280.34
Research & Development
19.1420.9822.9617.4414.96
Other Operating Expenses
18.88--15.39-
Total Operating Expenses
50.574345.3355.7240.25
Operating Income
-50.17-40.08-42.71-26.9846.06
Interest Income
0.981.963.40.70.05
Other Non-Operating Income (Expense)
0.680.541.197.43-0.47
Total Non-Operating Income (Expense)
1.652.54.68.13-0.43
Pretax Income
-48.51-37.58-38.11-18.8545.64
Provision for Income Taxes
-1.620.06-2.78-4.618.98
Net Income
-46.9-37.64-35.33-14.2436.66
Net Income to Common
-46.9-37.64-35.33-14.2436.66
Net Income Growth
-----13.70%
Shares Outstanding (Basic)
11111
Shares Outstanding (Diluted)
11111
Shares Change (YoY)
31.55%3.37%-6.77%5.27%6.80%
EPS (Basic)
-35.25-37.22-36.00-13.5038.10
EPS (Diluted)
-35.25-37.22-36.00-13.5036.90
EPS Growth
-----19.08%
Shares Outstanding
2.11.10.981.031.13
Free Cash Flow
-29.84-29.9-23.455.1440.41
Free Cash Flow Growth
----87.28%47.54%
Free Cash Flow Per Share
-22.43-29.57-23.974.9040.54
Gross Margin
64.28%74.48%38.57%83.98%88.18%
Operating Margin
-8058.83%-1023.75%-626.92%-78.85%47.06%
Profit Margin
-7533.62%-961.37%-518.68%-41.61%37.45%
FCF Margin
-4793.17%-763.78%-344.20%15.02%41.28%
EBITDA
-49.06-38.7-41.48-25.746.4
EBITDA Margin
-7881.03%-988.57%-608.86%-75.10%47.40%
EBIT
-50.17-40.08-42.71-26.9846.06
EBIT Margin
-8058.83%-1023.75%-626.92%-78.85%47.06%
Effective Tax Rate
3.33%-0.15%7.29%24.45%19.67%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.